Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma

Bone Marrow Transplant. 2024 Nov 15. doi: 10.1038/s41409-024-02472-3. Online ahead of print.
No abstract available

Publication types

  • Letter